122 East 102nd Street, Manhattan, NY 10029

The 5-story, 10-unit residential building at 122 East 102nd Street in East Harlem, owned by Uzi Evron, has experienced persistent reliability issues over the past few years. Most notably, there has been an ongoing heating and hot water system problem, with multiple complaints filed between 2022 and late 2023, including four separate complaints in November 2023 alone. While some heating issues were resolved promptly, others resulted in repeated complaints and emergency responses by the Department of Housing Preservation and Development (HPD).

The building has also faced significant plumbing challenges, including a December 2023 water supply issue that prompted immediate emergency attention. Recent health and maintenance concerns have come to light, with the property receiving Department of Health and Mental Hygiene (DOHMH) violations for rodent activity in 2024 and 2025, including uncured rat sightings and active rat activity noted during multiple inspections between 2024 and 2025. The building's 2023 violations specifically pertain to Unit 5B, revealing multiple maintenance issues including problems with the bathroom's porcelain enamel, wall surfaces, ceiling plaster, and tiles, as well as a leaky roof affecting both kitchen and bathroom ceilings. The property has maintained an active compliance record for bedbug reporting, showing no infested or re-infested units between 2022 and 2025.

Historical records from 2018-2020 indicate previous concerns about illegal hotel rooms, illegal activity, and construction site conditions, though these matters appear to have been resolved. Most recently, in 2024-2025, the building has been undergoing rodent control measures, with multiple bait applications and inspections indicating persistent rat activity. A new permit was issued in April 2024, suggesting recent maintenance or improvement efforts. The building's age (year built: 1910) and classification as an Old Law Tenement contribute to its unique history of maintenance challenges and regulatory oversight.